Roche's Avastin Misses Goal in Skin Cancer Study

Helvea. News of the failed study contrasts with positive studies presented earlier of rival products Nexavar, made by Bayer AG (BAY), and Erbitux, sold in Europe by Merck KGgA (MRK.XE). 'This is having a negative impact on sentiment, but won't change the...